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ABSTRACT
Background. Both arterial stiffness and systolic blood pressure
(BP) are established cardiovascular risk factors, yet little is
known about their interrelationship in chronic kidney disease
(CKD). The goal of this prospective study was to describe the
trajectory of aortic pulse wave velocity (PWV) and BP and to
compare the longitudinal interrelationship of BP (clinic and 24
h ambulatory recording) with the PWV.
Methods. Clinic BP was taken in two ways: at the time of the
measurement of the PWV (Clinic-S) and as an average of tripli-
cate measurements on three separate occasions within 1 week
(Clinic-M). 24 h ambulatory BP was measured using a validated
monitor and PWV was measured in the aorta using an echo-
Doppler technique.
Results. Among 255 veterans with CKD followed for over up to
4 years, the rate of change of log PWV was inversely related to
the baseline PWV; the trajectories were variable among individ-
uals and the net population change was no different from zero.
In contrast, systolic BP signiﬁcantly increased, but linearly, and
a strong relationship was seen between cross-sectional and lon-
gitudinal changes in Clinic-M systolic BP and log PWV. In con-
trast, a longitudinal relationship between Clinic-S and log PWV
was absent. In the case of 24-h ambulatory BP, a strong cross-
sectional change was seen between awake and 24 h systolic BP
but not between sleep BP and log PWV
Conclusion. In conclusion, among people with CKD, the PWV
changes over time and is inversely related to the baseline PWV.
An average of clinic BP measurements taken over three visits,
but not single measurements, are useful to assess the PWV and
its change over time. Differences exist between ambulatory BP
monitoring recording during the sleep and awake states in their
ability to predict the PWV. Taken together, these data support
the view that among those with CKD not on dialysis, targeting
clinic BP taken on multiple occasions using a standardized
methodology or daytime ambulatory systolic BP may slow the
progression of arterial damage.
Keywords: ambulatory blood pressure monitoring, arterial
stiffness, blood pressure, chronic renal failure, pulse wave
velocity
INTRODUCTION
Both hypertension and chronic kidney disease (CKD) are com-
mon in the adult US population [1] and they together account
for a large burden of cardiovascular morbidity, mortality and
costs associated with CKD [2]. Among veterans, CKD rivals
diabetes mellitus as a coronary risk equivalent [3]. Established
risk factors for cardiovascular disease include elevated arterial
stiffness and blood pressure (BP) [4]. Arterial stiffness is best






























































































































|Although both PWV and BP are powerful cardiovascular risk
factors, little information is available on how PWV evolves in
people with CKD not on dialysis. The cross-sectional relation-
ship between PWV and BP is well recognized, but among those
with CKD, how PWV changes over time and how BP predicts
this change is poorly understood.
The understanding of which BP measurement method pre-
dicts target organ damage as assessed by direct measurement of
PWV in the elastic aorta is important. This is because if one tech-
nique of BP measurement has a stronger relationship than the
other it would suggest that targeting that BP would be of greater
clinical importance. For example, although guidelines suggest
using multiple occasions for the measurement of clinic BP prior
to making clinical decisions, most clinical decisions are still made
using a single measurement occasion, which is at the time of the
clinic visit. Whether the ability to predict target organ damage is
similar in those with a single clinic BP measurement versus those
with multiple clinic measurements remains unknown.
Furthermore, accumulating evidence suggests that BP measure-
ments made outside the clinic may provide prognostically supe-
rior information [6–9]. However, the comparative value of BP
obtained in the clinic and that obtained using 24-h ambulatory
BP in assessing the PWV remains unclear.
In this study, the author explored the trajectory and pattern
of change of the PWV, clinic systolic BP and 24-h ambulatory
BP and compared the two types of clinic BP, measurement on a
single occasion (Clinic-S) and measurement on multiple occa-
sions (Clinic-M), in their ability to predict cross-sectional PWV
and its trajectory. Similarly, the author compared 24-h ambula-
tory BP measurement and its components, awake or sleep
ambulatory BP, for their ability to predict cross-sectional PWV
and its trajectory.
MATERIALS AND METHODS
Details of this cohort has been published previously [10].
Briefly, this was a prospective study of patients with CKD stages
2 through 4 [estimated glomerular filtration rate (GFR) defined
using the MDRD equation <90 mL/min/1.73 m2 but >15 mL/
min/1.73 m2]. For those with stage 2 CKD, albuminuria (A2 or
>300 mg/g creatinine) was required for inclusion in the cohort.
Those with an initial clinic BP of 140/90 mmHg were consid-
ered eligible and studied further. However, 10% of people
with a single clinic BP of 140/90 mmHg were found to be
hypertensive on further evaluation and were not excluded.
After obtaining a clinical history, performing a physical
examination and obtaining basic laboratory tests, measure-
ments of BP in the clinic [average of three visits (Clinic-M)] and
by 24-h ambulatory monitoring (24 h average) were performed
as reported earlier. BP measurements in triplicate were also
obtained independent of the three clinic visits at the time of the
PWV measurement. BP obtained during the PWV measure-
ment was called the single-visit clinic BP (Clinic-S).
Classification of hypertension
The original definition of masked hypertension proposed by
Pickering et al. [11] and the one used by the International
Database on Ambulatory Blood Pressure in Relation to
Cardiovascular Outcomes (IDACO) investigators [12] do not
take into account BP recordings at night. Accordingly, masked
uncontrolled hypertension was defined as controlled clinic BP
(<140/90 mmHg on average of three clinic visits by oscillomet-
ric BP measurement) but elevated ambulatory BP [13]. Elevated
ambulatory BP was defined as elevated daytime (135/85
mmHg) BP. To define daytime and nighttime, we used patient
diaries. Elevated ambulatory BP was also defined in two other
ways: (i) elevated 24-h (130/80 mmHg); and (ii) either ele-
vated daytime or elevated nighttime (120/70 mmHg) ambula-
tory BP.
PWV measurements
Arterial stiffness was assessed by measuring the aortic PWV
through direct visualization of the descending aorta with the
use of an echo-Doppler technique (Acuson Cypress, Seimens
Medical). The flow pulse was recorded by continuous Doppler
from the root of the left subclavian artery and just proximal to
the bifurcation of the abdominal aorta with simultaneous elec-
trocardiographic recording [14]. The length of the descending
aorta was estimated by measuring the body surface distance
from the suprasternal notch to the recording site of the aortic
signal (near the umbilicus). The time elapsed from the peak of
the R wave to the foot of the systolic impulse was recorded over
six beats. The length of the descending aorta divided by the dif-
ference between transit times was calculated to yield the aortic
PWV [14].
Statistical analysis
Line graphs of individual level data were generated and rela-
tionships of slopes and intercepts plotted prior to model fitting.
Linear mixed models were then used to assess the trajectory of
the PWV and BP over time [15]. A random coefficient model
was fitted [16]. BP was modeled separately for each measure-
ment type (Clinic-S, Clinic-M, 24 h ambulatory, awake ambula-
tory, sleep ambulatory).
Because all BP measurements were obtained in the same par-
ticipants, the beta coefficients for PWV change were not multi-
ply adjusted for differences in confounders. This was because
the question of what the independent predictors of PWV change
are was not being asked; the BP values were simply being com-
pared as to their relative ability to predict PWV change. When
comparing different BP measurements and outcomes, a similar
approach has been adopted by us and others [17, 18].
All statistical analyses were done with Stata 14.0 (Stata Corp,
College Station, TX, USA). The nominal level of statistical sig-
nificance was taken as a two-sided P of 0.05.
RESULTS
Baseline characteristics of participants are given in Table 1. As
expected of a veteran population, participants were older,
mostly White men, and two-thirds were past smokers. Notable
was a high prevalence of diabetes mellitus and cardiovascular
disease ascertained by a review of medical records. The average
estimated GFR was 44 mL/min/1.73 m2 and the median urinary
P W V a n d a m b u l a t o r y B P m o n i t o r i n g i n C K D 1851Downloaded from https://academic.oup.com/ndt/article-abst act/32/11/1850/3059452
by Ruth Lilly Medical Library user























|albumin/creatinine ratio was 30 mg/g (interquartile range 8–
280 mg/g). All but four participants were receiving antihyper-
tensive drugs for BP control and the average number of antihy-
pertensive drugs used was 3.1. At baseline, the Clinic-S
measurement was 134/72 mmHg and the average Clinic-M was
much lower at 121/60 mmHg. On average the 24-h ambulatory
BP was 127/69 mmHg (123/66 mmHg during sleep and 130/72
mmHg during the awake state).
Participants who had more than one measurement of the
PWV were well matched to the overall sample, as illustrated in
Table 1.
Growth models of PWV and ambulatory systolic BP
Figure 1 shows the individual plots of each participant for
the PWV, clinic and ambulatory BP measurements. The mean
change is shown by the superimposed linear regression line. A
linear change appears apparent for BP and no change for the
PWV. Figure 2 shows the relationship between slopes and inter-
cepts derived from each individual participant by ordinary least
squares regression. Error bars of the slopes are shown where
more than two measurements of the PWV or BP were available.
Slopes of the PWV showed an inverse log–linear relationship
with baseline PWV. Slopes of BP showed an inverse relation-
ship with baseline BP in each case.
Table 2 shows the taxonomy of models for PWV, clinic and
ambulatory BP measurements. In each case, the unconditional
means model is described followed by the growth curve model.
The unconditional means model accounts for the nested nature
of the observations within participants. The natural log of PWV
was taken as the outcome variable to normalize the data. The
unconditional geometric mean PWV was 7.1 m/s (exponent of
1.96). The between-subject standard deviation (SD) of the log-
Table 1. Baseline characteristics of the study sample
Overall Group with >1 PWV PWV decreased PWV increased P-value
Number of participants, n (%) 255 66 28 (42.4%) 38 (57.5%)
Age (years) 69.46 9.9 67.46 9.9 66.76 11.5 67.96 8.6 >0.2
Male sex, n (%) 249 (97.6%) 65 (98.4%) 27 (96.4%) 38 (100%) >0.2
Race, n (%)
White 201 (78.8%) 50 (75.7%) 21 (75%) 29 (76.3%) >0.2
Black 47 (18.4%) 16 (24.2%) 7 (25%) 9 (23.6%)
Other 7 (2.74%)
Height (in) 174.76 7.8 174.66 7.4 173.26 7.1 175.76 7.6 0.18
Weight (kg) 94.26 16.6 93.36 16.3 93.86 15.6 936 17 >0.2
Body mass index (kg/m2) 30.86 4.6 30.56 4.4 31.26 4.4 306 4.4 >0.2
Diabetes mellitus, n (%) 167 (65.4%) 45 (68.1%) 20 (71.4%) 25 (65.7%) >0.2
Myocardial infarction, n (%) 74 (29.0%) 23 (34.8%) 7 (25%) 16 (42.1%) 0.15
Coronary artery bypass graft, n (%) 55 (21.5%) 22 (33.3%) 8 (28.5%) 14 (36.8%) >0.2
Congestive heart failure, n (%) 48 (18.8%) 15 (22.7%) 4 (14.2%) 11 (28.9%) 0.16
Peripheral vascular disease, n (%) 53 (20.7%) 13 (19.6%) 7 (25%) 6 (15.7%) >0.2
Smoking, n (%)
Never 42 (16.4%) 9 (13.6%) 4 (14.2%) 5 (13.1%) >0.2
Past 175 (68.6%) 45 (68.1%) 18 (64.2%) 27 (71.0%)
Current 38 (14.9%) 12 (18.1%) 6 (21.4%) 6 (15.7%)
Laboratory tests
Albumin (g/dL) 3.946 .47 4.056 .38 4.16 .45 4.026 .32 >0.2
Hemoglobin (g/dL) 13.26 1.7 13.36 2.1 13.26 2.1 13.56 2 >0.2
Estimated GFR (mL/min/1.73 m2 ) 43.66 15.6 46.76 18.6 50.86 23 43.76 14 0.12
Log urine albumin/creatinine ratio 3.246 2.19 3.366 2.15 3.036 2.24 3.616 2.08 >0.2
Antihypertensive drugs (n) 3.16 1.4 3.26 1.6 36 1.1 3.36 1.8 >0.2
Angiotensin-converting enzyme inhibitors, n (%) 129 (51.3%) 37 (56.0%) 17 (60.7%) 20 (52.6%) >0.2
Angiotensin receptor blockers, n (%) 56 (22.3%) 16 (24.2%) 7 (25%) 9 (23.6%) >0.2
b-Blockers, n (%) 168 (66.9%) 42 (63.6%) 19 (67.8%) 23 (60.5%) >0.2
Single-visit clinic systolic BP (mmHg) 135.26 19.8 132.76 16.2 133.16 16.3 132.56 16.3 >0.2
Single-visit clinic diastolic BP (mmHg) 72.36 12.2 73.96 10.9 73.16 10.6 74.56 11.3 >0.2
Single-visit clinic pulse rate (beats/min) 65 6 11.7 63.56 11.8 62.66 12.2 64.16 11.6 >0.2
Multiple-visit clinic systolic BP (mmHg) 1226 14.8 120.36 14.1 120.96 13.6 119.86 14.6 >0.2
Multiple-visit clinic diastolic BP (mmHg) 60.86 10.5 59.46 10.5 58.26 11 60.36 10.1 >0.2
Multiple-visit clinic pulse rate (beats/min) 66.36 11.7 64.16 11.8 63.96 13.4 64.36 10.6 >0.2
24 h ambulatory systolic BP (mmHg) 128.46 14.1 128.76 14 127.76 14.7 129.46 13.6 >0.2
24 h ambulatory diastolic BP (mmHg) 69.96 9.6 70.16 8.9 686 9.1 71.66 8.6 0.11
24 h ambulatory pulse rate (beats/min) 68.86 10.6 67.56 11 67.36 12.1 67.76 10.2 >0.2
Sleep ambulatory systolic BP (mmHg) 124.66 16.1 124.66 14.8 122.46 15.5 126.46 14.3 >0.2
Sleep ambulatory diastolic BP (mmHg) 66.16 10.4 66.66 9.7 64.16 9.2 68.56 9.8 0.07
Sleep ambulatory pulse rate (beats/min) 65.66 10.3 64.36 10.2 63.36 9.8 65.16 10.6 >0.2
Awake ambulatory systolic BP (mmHg) 130.76 14.1 131.16 14.3 130.86 14.8 131.36 14 >0.2
Awake ambulatory diastolic BP (mmHg) 72.16 9.8 72.36 9.3 70.56 10 73.66 8.6 0.18
Awake ambulatory pulse rate (beats/min) 70.66 11.3 69.56 12.1 69.96 13.9 69.26 10.6 >0.2
Data are presented as mean 6 SD or n (%). P-values reﬂect signiﬁcance of differences between groups in which the PWV increased versus those in which the PWV decreased. Missing
data on 1 for albumin, 2 for urine albumin and 2 for ambulatory in the overall sample.
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transformed data may be interpreted as the coefficient of varia-
tion, or test–retest reliability, which was 16.3%. There was no
overall change in the PWV with some participants showing an
increment on the PWV, whereas others showed decrements.
Table 1 gives the baseline characteristics of participants who
have a PWV slope of <0 versus those who had a slope of >0.
The two groups had no imbalance in any of the characteristics
that could meaningfully change the slopes. Accordingly, there
did not appear to be heterogeneity in the baseline characteristics
that likely accounted for the variability in the slopes.
Single clinic systolic BP showed a large amount of variability
within participants with intraclass correlation coefficient over
years approaching zero. Multiple clinic BP values averaged 121.9
with a between-subject SD of 8.6 mmHg (intraclass correlation
coefficient was 0.31). On average clinic BP (Clinic-M) increased
by 2.1mmHg/year. Themagnitude of increase in 24-h ambulatory
BP was less at 1.7 mmHg/year; however, the intraclass correlation
coefficient was 0.41. Notably, the growth in sleep ambulatory BP
was 2.3 mmHg/year, which was 64% more than that seen during
the awake state. Furthermore, compared with the awake ambula-
tory systolic BP, numerically there was greater test–retest reliability
for sleep ambulatory BP (intraclass correlation coefficient for
awake BP being 0.32 and that for sleep BP being 0.50).
PWV and its relationship with clinic and ambulatory BP
The relationship of systolic BP growth and PWV was ana-
lyzed using mixed models and is summarized in Figure 3. In the
case of single clinic BP measurement, every 10 mmHg increase
in systolic BP across individuals was associated with a 3.34%
increase in the PWV (this is shown as the intercept). Intra-
individual increase of 10 mmHg in clinic systolic BP was associ-
ated with non-significant 0.51% growth in the PWV. In con-
trast, multiple clinic BP measurements were associated with a
4.69% greater PWV at baseline and 4.15% growth over time per
10 mmHg increment in systolic BP. These results were signifi-
cant as noted by the P-values and the 95% confidence intervals
not crossing 0. In comparison, for 24-h ambulatory BP [3.6%
intercept, 2.3% (not significant, NS) slope], cross-sectional asso-
ciations were positive and longitudinal associations were not.
Furthermore, daytime ambulatory systolic BP [3.6% intercept,
2.8% slope (NS)] and sleep ambulatory BP [2.4% intercept (NS)
0.8% slope (NS)] show greater predictive power in the awake
than in the sleep state (likelihood ratio test of nested models P
¼ 0.027).
DISCUSSION
Although CKD is said to be a state of accelerated vascular age-
ing, among 255 veterans with CKD, over the 2–4 years of
follow-up, we found little change in the mean PWV. Thus, secu-
lar increase in the PWV is not a fact of ageing in CKD; this is
consistent with several reports among hemodialysis patients.
Guerin et al. over a mean follow-up of 51 months reported a
FIGURE 1: Trajectories of the PWV and BP over 4 years. Lines represent each individual participant. Circles at time zero are those who had a
baseline measurement. Ambulatory BP monitoring was performed over 24 h. Clinic BP at a single visit (Clinic-S) and multiple visits (Clinic-M)
are as described in the Materials and methods section.
P W V a n d a m b u l a t o r y B P m o n i t o r i n g i n C K D 1853Downloaded from https://academic.oup.com/ndt/article-abst act/32/11/1850/3059452
by Ruth Lilly Medical Library user







decline in the PWV of 1.32 m/s in 100 patients and an increase
of 0.95 m/s in 50 patients [19]. The mean change was therefore
a decline of 0.85 m/s. London et al. reported, over a mean
follow-up of 54 months of 153 hemodialysis patients, the base-
line carotid-to-femoral PWV to be 11.15 m/s, which at the end
of the follow-up was similar to that at baseline (11.03 m/s) [20].
However, PWV changes associate with systolic BP, which is
akin to what is reported in hemodialysis patients [19, 21].
Although it is possible that BP influences the PWV or vice versa,
it is also likely that unmeasured factors such as volume
FIGURE 2: Relationship of ordinary least square (OLS) slopes and intercepts for individual participants. Error bars represent the standard error
of the estimate in those participants who had three measurements. Baseline PWV is plotted on a log scale. All participants who had baseline
PWV of <5 m/s had growth in PWV, whereas some with a PWV >5 m/s at baseline had regression of PWV. A-sysBP ¼ ambulatory systolic
BP.
Table 2. Taxonomy of models for the PWV and systolic ambulatory BPs
Parameter Intercept Slope P for slope r0 r1 r01 re
Natural log of PWV (m/s) log units/year
Unconditional means only 1.960 (1.921–1.999) 0.163 0.302
Unconditional slope model 1.954 (1.911–1.996) 0.015 (0.019–0.049) 0.39 0.2 0.052 0.56 0.284
Single clinic systolic BP (mmHg) mmHg/year
Unconditional means only 135.4 (133.2–137.5) 0.00 20.00
Unconditional slope model 133.9 (131.6–136.3) 2.8 (0.5–5.1) 0.018 0.44 2.88 1.00 19.51
Multiple clinic systolic BP (mmHg)
Unconditional means only 121.9 (120.1–123.6) 8.61 12.72
Unconditional slope model 121.0 (119.1–122.8) 2.1 (0.6–3.6) 0.005 8.67 0.27 1.00 12.41
24 h ambulatory systolic BP
Unconditional means only 128.0 (126.3–129.8) 9.38 11.18
Unconditional slope model 127.4 (125.7–129.2) 1.7 (0.2–3.2) 0.023 10.38 2.67 0.29 10.12
Sleep ambulatory systolic BP
Unconditional means only 123.8 (121.9–125.8) 11.73 11.83
Unconditional slope model 123.1 (121.1–125.1) 2.3 (0.6–4.0) 0.008 12.96 3.74 0.16 9.97
Awake ambulatory systolic BP
Unconditional means only 130.5 (128.8–132.2) 8.23 12.04
Unconditional slope model 129.9 (128.1–131.7) 1.4 (0.1–2.8) 0.062 9.17 1.68 0.58 11.47
Numbers in parenthesis are the 95% conﬁdence intervals.
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expansion may influence both outcomes: BP and PWV; thus a
causal relationship should not be assumed. In contrast to the
change in the PWV, longitudinal change in systolic BP was sig-
nificantly different: it increased, and it did so linearly, 1.7
mmHg/year by clinic measurements and 1.8 mmHg/year by
24-h ambulatory BP measurements. Furthermore, the growth
in sleep systolic BP was 60% more than that in awake ambula-
tory BP.
The question emerges whether it is possible to assume a rela-
tionship between the PWV and BP, one of which (PWV) did
not change, on average, during the follow-up, in the whole pop-
ulation, and the other increased in a linear manner over time.
This phenomenon can be better understood by dissecting out
intra-individual change from changes in the group over time.
Our data show that individuals who have an increase in the
PWV also have an increase in BP. Similarly, individuals who
have a fall in the PWV also have a fall in BP. Thus the two are
related. At the group level, there is no change in the PWV and
only a slight change in BP. However, this does not mean that
the two measures do not go hand-in-hand. The random coeffi-
cient model evaluates the individual-level information and
group-level information within the same model and has the
power to detect the relationship at the individual level and the
group level separately. Thus, the observations noted here are
not inconsistent. Furthermore, the change in the PWV was
related to baseline PWV; this is an important phenomenon of
regression to the mean. In other words, those with a high PWV
had a drop in the PWV over 2 years and those with a low PWV
at baseline had a rise over 2 years. This is a phenomenon also
noted for the left ventricular mass index [22].
Multiple clinic BP measurements were superior to single
clinic BP measurement, taken at the time of PWV measure-
ment, in predicting PWV velocity change. This may be because
multiple clinic measurements may better reflect the intra-
arterial pressure. Although a single clinic BP measurement was
associated with among-participant differences in the PWV, it
was unable to predict the change in the PWV over time. This
suggests that carefully taken, standardized measurements of BP
are particularly important for long-term studies.
Awake ambulatory BP was capable of detecting differences
in the PWV among individuals but not over time. In contrast,
sleep ambulatory BP was unable to discern among-individual
differences in the PWV or in its longitudinal change. The
author speculates that the awake and sleep BPmay reflect differ-
ent domains of arterial health. The awake BP is influenced by
activity; in CKD we have previously reported that activity-
induced changes in BP are greater in those who have been less
physically active [23]. Thus, greater awake BP may reflect a
more sedentary lifestyle associated with other cardiovascular
risks. Variations in awake pressure through inducing pulsatile
stress may stimulate more adventitial fibrosis. In contrast, sleep
pressure may reflect static load and have less relevance to the
progression of arterial stiffness.
The study noted that ambulatory BP was similar to well-
measured oscillometric clinic systolic BP in determining the
PWV at baseline and its growth over time; there were no differ-
ences in model fit. This attests to the value of well-measured
clinic BP in long-term studies for the prediction of arterial stiff-
ness. However, it should be noted that single clinic measure-
ment was on average 14 mmHg higher than the average of three
clinic visits. Still, most clinical decisions to treat or not to treat
hypertension are based on a single BP measurement made at a
clinic visit. Targeting BP obtained at a single clinic visit is ques-
tionable. In this study, multiple visits (three visits with each BP
recording in triplicate over 1 week) were required for the detec-
tion of growth of the PWV over time. A single clinic BP meas-
urement performed at the time of PWV assessment by Doppler
ultrasound was unable to detect the growth of the PWV over
time. These findings have implications for quality improvement
programs and the design of interventional studies.
Limitations of the study include the following: participation
in the study was restricted to veterans who are older and are
predominantly men. Whether our findings apply to younger
people and women will need to be clarified in future studies.
Risk factors such as age, male sex, anemia, progression of kidney
disease and the occurrence of cardiovascular disease may well
produce PWV growth. Because all the measurements were
made in the same group of participants, we did not make any
adjustments simply because we could compare BP measure-
ment techniques in a paired manner. Because all the analyses
are unadjusted, we cannot conclude that BP is independently
associated with PWV growth.
There are several strengths of our study: our study used 24-h
ambulatory blood pressure monitoring, the gold-standard
method to diagnose out-of-office hypertension. Our study was
prospective; it carefully collected information on Doppler-
assessed PWV solely for the purposes of the study. BP pattern
assessment in each individual using several BP monitoring
methods used both a single visit at the time of PWV assessment,
and multiple clinic visits to define clinic hypertension, had a
high completion rate.
In conclusion, among patients with CKD, nearly all of whom
were taking antihypertensive medications, PWV growth is vari-
able unlike the increase in both clinic and ambulatory BP.
FIGURE 3: Mixed model estimates of percent change in the PWV
per 10 mmHg change in systolic BP. The abscissa shows the various
types of BP measurements. The intercept represents the cross-sec-
tional association of the PWV, whereas the slope represents the lon-
gitudinal association. Multiple clinic BP measurements were superior
to a single clinic BP measurement in predicting PWV growth. Awake
ambulatory BP monitoring (ABPM) was superior to sleep ABPM in
predicting PWV growth.
P W V a n d a m b u l a t o r y B P m o n i t o r i n g i n C K D 1855Downloaded from https://academic.oup.com/ndt/article-abst act/32/11/1850/3059452
by Ruth Lilly Medical Library user























































































|Given that the growth of BP and that of PWV are concordant,
attempts to control hypertension may be useful to abrogate the
rate of PWV over time. BP recorded over three visits and aver-
aged was as good as ambulatory BP monitoring and superior to
a single recording of clinic BP in predicting the progression of
arterial stiffness. In the usual day-to-day care of patients, it is
unlikely that clinic BP will have such predictive power.
Nonetheless, the study illustrates the value of well-taken clinic
BP in its ability to predict between-individuals and within-
individual changes in target organ damage. Differences exist
with respect to the independent contributions of sleep and
awake ambulatory BP on PWV growth. This may be due to the
pulsatile nature of the stress that may be better captured using
the awake ambulatory BP monitoring. Taken together, these
data support the view that targeting clinic BP taken on multiple
occasions using a standardized methodology or daytime ambu-
latory systolic BPmay slow the progression of arterial damage.
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